The two companies focus on research, development and commercialization of sterile packaged implants and surgical tools for spinal fusion.
Back 2 Basics Direct and Orbbö Surgical represent Wishbone Medical’s fifth and sixth acquisitions in the past 18 months, according to an Aug. 5 announcement.
The acquisitions add nine FDA-cleared spinal fusion products to Wishbone Medical’s portfolio, which is expected to bring more than $12 million in year one revenue for the company.
Twenty spine-focused employees will be added to Wishbone Medical’s global team of 165.
More articles on devices:
Acquisitions, leadership changes & more: 6 big moves from Medtronic
Zimmer Biomet’s worldwide knee sales plummet 46.8% in Q2, hitting $374M
9 spine surgeons stepping into new leadership roles
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
